throbber

`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`APPLE INC.,
`
`Petitioner
`v.
`
`JAWBONE INNOVATIONS, LLC,
`
`Patent Owner
`
`
`
`
`
`
`
`
`
`Case IPR2022-01084
`
`U.S. Patent No. 8,321,213
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S PRELIMINARY REPLY
`
`
`
`
`
`
`

`

`
`
`
`
`
`
`IPR2022-01084
`U.S. Patent No. 8,321,213
`
`
`PETITIONER’S UPDATED EXHIBIT LIST
`
`APPLE-1001
`
`U.S. Patent No. 8,321,213 to Petit et al. (“the ’213 patent”)
`
`APPLE-1002
`
`Excerpts from the Prosecution History of the ’213 patent (“the
`Prosecution History”)
`
`APPLE-1003
`
`Declaration of Dr. Thomas Kenny
`
`APPLE-1004
`
`Curriculum Vitae of Dr. Thomas Kenny
`
`APPLE-1005
`
` U.S. Patent No. 8,194,880 B2 (“Avendano”)
`
`APPLE-1006
`
` U.S. Patent No. 7,464,029 B2 (“Visser”)
`
`APPLE-1007
`
` RESERVED
`
`APPLE-1008
`
` U.S. Patent No. 7,155,019 B2 (“Hou”)
`
`APPLE-1009
`
` Byrne, D, et al, “An international comparison of long-term
`average speech spectra,” 1994 Oct; J. Acoust. Soc. Am.; 96(4):
`2108-2120 (“Byrne”).
`
`APPLE-1010
`
` U.S. Publication No. US 2011/0103626 A1 (“Bisgaard”)
`
`APPLE-1011
`
` U.S. Provisional App. No. 60/816,244 (“the Bisgaard
`Provisional”)
`
`APPLE-1012
`
` U.S. Publication No. US 2002/0198705 A1 (“Burnett”)
`
`APPLE-1013
`
` Berglund, B, et al, “Source and effects of low-frequency noise,”
`1996 May; J. Acoust. Soc. Am; 99(5): 2985-3002 (“Berglund”).
`
`APPLE-1014
`
` Declaration of June Ann Munford
`
`APPLE-1015
`
` Declaration of June Ann Munford - Appendix
`
`
`
`i
`
`

`

`
`
`
`APPLE-1016
`
`
`
`
`IPR2022-01084
`U.S. Patent No. 8,321,213
`
`
` Curriculum Vitae of June Ann Munford
`
`APPLE-1017
`
` RESERVED
`
`APPLE-1018
`
` Ryan David, Positive COVID Tests Derail Intel Patent Trial In
`WDTX, LAW360 (Apr. 26, 2022, 1:16PM),
`https://www.law360.com/articles/1487451
`
`APPLE-1019
`
` Dani Kass, Fintiv Fails: PTAB Uses ‘Remarkably Inaccurate’
`Trial Dates, LAW360 (Nov. 2, 2021, 9:09 PM),
`https://www.law360.com/articles/1436071
`
`APPLE-1020
`
` Motion to Transfer (Public Version) – Jawbone Innovations,
`LLC v. Apple Inc., 6:21-cv-00984, D.I. 47 (W.D. Tex. May 6,
`2022)
`
`APPLE-1021
`
` Motion to Transfer (Public Version) – Jawbone Innovations,
`LLC v. Google LLC, 6:21-cv-00985, D.I. 43 (W.D. Tex. Apr.
`29, 2022)
`
`APPLE-1022
`
` Motion to Transfer – Jawbone Innovations, LLC v.
`Amazon.com, Inc., 2:21-cv-00435, D.I. 25
`(E.D. Tex. Mar.
`10, 2022)
`
`APPLE-1023
`
` Complaint – Jawbone Innovations, LLC v. Apple Inc., 6:21-cv-
`00984, D.I. 1 (W.D. Tex. Sep. 23, 2021)
`
`APPLE-1024
`
` Scheduling Order – Jawbone Innovations, LLC v. Apple Inc.,
`6:21-cv-00984, D.I. 23 (W.D. Tex. Jan. 7, 2022)
`
`APPLE-1025
`
` Press Release of U.S. Senator Patrick Leahy of Vermont
`
`APPLE-1026
`
` Legislative Proposal - Restoring the America Invents Act
`
`APPLE-1027
`
` Complaint – Jawbone Innovations, LLC v. Google LLC, 6:21-
`cv-00985, D.I. 1 (W.D. Tex. Sep. 23, 2021)
`
`
`
`
`
`ii
`
`

`

`
`
`
`APPLE-1028
`
`
`
`
`
`
`
`
`
`
`IPR2022-01084
`U.S. Patent No. 8,321,213
`
`
` Amended Scheduling Order – Jawbone Innovations, LLC v.
`Apple Inc., 6:21-cv-00984, D.I. 23 (W.D. Tex. Oct. 20, 2022)
`
`iii
`
`

`

`
`
`
`
`
`
`IPR2022-01084
`U.S. Patent No. 8,321,213
`
`
`I.
`INTRODUCTION
`Petitioner below addresses the proper application of the Fintiv factors under
`
`the USPTO’s Interim Procedure for Discretionary Denials (“Guidance”), and
`
`demonstrates that denial would be inappropriate.
`
`II.
`
`FINTIV FACTORS 1-4 AND 6 STRONGLY FAVOR
`INSTITUTION
`A.
`Petitioner Intends to File a Motion to Stay the Parallel
`Litigation (Factor 1)
`Neither party to the litigation has yet requested a stay, but a stay remains
`
`possible. Indeed, Apple’s motion for transfer to the Northern District of California
`
`(“NDCA”) remains pending and, if granted, stay pending institution is likely.
`
`Nevertheless, upon institution of this petition and regardless of the transfer
`
`decision, Petitioner intends to file a motion to stay the parallel litigation.
`
`Accordingly, as noted in the Petition, Factor 1 is at worst neutral (Pet. 94).
`
`B.
`
`The Final Written Decision Deadline Precedes the Median
`Trial Date (Factor 2)
`In June, Director Vidal issued clear guidance on the trial date to use when
`
`considering discretionary denial on the basis of co-pending litigation. Specifically,
`
`“when considering the proximity of the district court’s trial date to the date when
`
`the PTAB final written decision will be due, the PTAB will consider the median
`
`time from filing to disposition of the civil trial for the district in which the parallel
`
`
`
`1
`
`

`

`
`
`
`
`
`
`IPR2022-01084
`U.S. Patent No. 8,321,213
`
`
`litigation resides” and cited to statistics.1 Guidance, 3. These statistics show the
`
`“most recent statistics on median time-to-trial for civil actions” in the Western
`
`District of Texas (“WDTX”) as 28.3 months. Here, the complaint against Apple
`
`was filed on September 23, 2021 (APPLE-1009), establishing an expected trial
`
`date of February 2024 based on the WDTX statistics.2 Accordingly, the median
`
`time-to-trial falls after the statutory deadline for the Board’s final written decision
`
`(“FWD”), which is expected to be no later than December 21, 2023.
`
`Patent Owner asks the Board to ignore this guidance and, instead, use the
`
`July 26, 2023 trial date in the scheduling order entered on January 7, 2022.
`
`However, as the Director explained “scheduled trial dates are unreliable and often
`
`change.” Indeed, the district court recently delayed the trial to September 27, 2023
`
`in the amended scheduling order entered on October 20, 2022. APPLE-1028. That
`
`a Markman hearing has not yet been held, and that Apple’s motion to transfer
`
`
`
` Available at https://www.uscourts.gov/statistics/table/na/federal-court-
`
` 1
`
`management-statistics/2022/06/30-2
`
`2 Twenty-eight months from the September 23, 2021 complaint against Apple falls
`
`on January 23, 2024. Thirty percent (i.e., 0.3) of the thirty-one days in January
`
`2024 adds 9.3 days and moves the median time-to-trial to February 1, 2024.
`
`
`
`2
`
`

`

`
`
`
`
`
`
`IPR2022-01084
`U.S. Patent No. 8,321,213
`
`
`remains pending, further underscores the uncertainty as to whether and when the
`
`Apple litigation might proceed to trial.
`
`Thus, due to demonstrable unreliability of scheduled trial dates, the Board
`
`should follow the Director’s guidance, i.e., use median time to trial, and find
`
`Factor 2 to favor institution.
`
`However, even if the currently scheduled trial date (September 27, 2023) is
`
`considered, Factor 2 is, at worst, neutral because the Board considers the proximity
`
`of the parallel proceeding to the FWD. When the FWD is due shortly after the
`
`target date—here, at worst, by roughly two and a half months—this factor receives
`
`little weight. Sotera Wireless, Inc. v. Masimo Corp., IPR2020-01019, Paper 12, 15
`
`(2020). Also, “given the minimal, if any, overlap between the issues in the [co-
`
`pending litigation] and this proceeding,” which is the case here as explained in Part
`
`D below, “the time overlap has less significance.” SharkNinja v. iRobot Corp.,
`
`IPR2021-00545, Paper 11, 7 (2021).
`
`C.
`Petitioner’s Diligence Favors Institution (Factor 3)
`The Petition was filed approximately eight months after being served with
`
`the complaint, approximately four months after Jawbone served infringement
`
`contentions, and less than two months after Apple served preliminary invalidity
`
`contentions. With this diligence, the investment in the district court “is not a result
`
`of Petitioner’s delay.” SharkNinja, IPR2021-00545, Paper 11 at 7-8. In fact, the
`
`
`
`3
`
`

`

`
`
`
`
`
`
`IPR2022-01084
`U.S. Patent No. 8,321,213
`
`
`deadline to amend pleadings (December 20, 2022) falls before the institution
`
`deadline and significant events (e.g., several months of fact discovery, expert
`
`reports, dispositive motions, a Markman hearing, trial, etc.) will occur in the
`
`district court post-institution. Indeed, a Markman hearing has not yet been held,
`
`Apple’s motion to transfer remains pending, and much of the case remains to be
`
`litigated. Thus, Factor 3 favors institution.
`
`D.
`Petitioner’s Stipulation Favors Institution (Factor 4)
`Patent Owner’s argument that Petitioner has not provided a Sotera
`
`stipulation does not change the weight that should be accorded to Petitioner’s Sand
`
`Revolution stipulation, which resolves doubt as to meaningful overlap of issues
`
`(Pet. 98-99). Sand Revolution II, LLC v. Cont’l Intermodal Grp.-Trucking LLC,
`
`IPR2019-01393, Paper 24 at 11-12 (June 16, 2020).
`
`Specifically, Petitioner’s stipulation prevents overlap because it requires the
`
`grounds addressed in each forum to be mutually exclusive, thereby obviating the
`
`possibility of inconsistent results. With institution, the IPR grounds will not be
`
`considered in the litigation and the same grounds will not be evaluated in both
`
`forums, thereby reducing inefficiency and the risk of inconsistent results.
`
`Moreover, upcoming events in the litigation will dictate a reduction in
`
`overlap between this proceeding and the issues that will be litigated through trial.
`
`In fact, Final Invalidity and Infringement Contentions are not due until December
`
`
`
`4
`
`

`

`
`
`
`
`
`
`IPR2022-01084
`U.S. Patent No. 8,321,213
`
`
`13, 2022. APPLE-1028, 1. Also, the court has set deadlines of January 25, 2023
`
`and February 15, 2023 for “meet and confers to discuss significantly narrowing
`
`the number of claims asserted and prior art references at issue to triable limits.”
`
`APPLE-1028, 2. Accordingly, as litigation progresses, the overlap in claim
`
`coverage and/or prior art is almost certain to reduce even more.
`
`E.
`The Compelling Merits Favor Institution (Factor 6)
`The Director’s guidance also confirmed that “the PTAB will not rely on the
`
`Fintiv factors to discretionarily deny institution … where a petition presents
`
`compelling evidence of unpatentability.” Here, as demonstrated in the Petition with
`
`reference to Dr. Kenny’s testimony and additional supporting evidence, the
`
`Petition’s merits are “compelling,” and, as a result, a compelling case of
`
`unpatentability obviates the Board’s need to address the Fintiv factors at all.
`
`Further, although the Patent Owner criticizes Petitioner’s application of the cited
`
`references, the Patent Owner does so solely on the basis of attorney argument that
`
`is unsupported by expert testimony or any other extrinsic evidence.
`
`For the reasons set forth above and in the petition, a holistic view of the
`
`Fintiv factors supports institution.
`
`
`
`
`
`
`
`
`
`5
`
`

`

`Date: October 24, 2022
`
`Respectfully submitted,
`
`IPR2022-01084
`U.S. Patent No. 8,321,213
`
`/Jeremy J. Monaldo/
`W. Karl Renner, Reg. No. 41,265
`Jeremy Monaldo, Reg. No. 58,680
`Richard Wong, Reg. No. 73,259
`Fish & Richardson P.C.
`3200 RBC Plaza, 60 South Sixth Street
`Minneapolis, MN 55402
`T: 202-783-5070
`F: 877-769-7945
`Attorneys for Petitioner
`
`

`

`IPR2022-01084
`U.S. Patent No. 8,321,213
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR § 42.6(e), the undersigned certifies that on October 24,
`
`2022, a complete and entire copy of this Petitioner’s Preliminary Reply was
`
`provided via email to the Patent Owner by serving the correspondence email
`
`addresses of record as follows:
`
`Peter Lambrianakos
`Vincent J. Rubino III
`Alfred R. Fabricant
`Enrique W. Iturralde
`Richard Cowell
`FABRICANT LLP
`411 Theodore Fremd Avenue, Suite 206 South
`Rye, New York 10580
`Tel. 212-257-5797
`Fax. 212-257-5796
`
`plambrianakos@fabricantllp.com
`vrubino@fabricantllp.com
`ffabricant@fabricantllp.com
`eiturralde@fabricantllp.com
`rcowell@fabricantllp.com
`ptab@fabricantllp.com
`
`/Crena Pacheco/
`Crena Pacheco
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(617) 956-5938
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket